NAIT and API entered a strategic partnership, combining expertise and facilities to bolster training and support for professionals in the life sciences sector.
The recently announced partnership leverages NAIT's Centre for Advanced Medical Simulation (CAMS) to provide space and services for comprehensive usability and validation studies for life sciences innovators. By utilizing state-of-the-art simulation environments, health and life sciences entrepreneurs and startups can reduce the costs that can occur with testing and validating innovations and accelerate product development cycles.
The collaboration builds on a longstanding relationship, enhancing API's role as a key partner in prescription drug development and regulatory expertise with the capacity of CAMS at NAIT to accelerate health innovations in a simulated environment.
Additionally, API and CAMS will forge stronger connections between industry and academia, fostering the training and development of qualified professionals and promoting interdisciplinary experiences and interprofessional health education opportunities. This partnership aims to solidify Edmonton's leadership in the life sciences innovation ecosystem.
LEARN MORE
- API and NAIT Forge New Partnership to Boost Life Sciences Innovation
- About API
- About Centre for Advanced Medical Simulation at NAIT
Quotes
"We are thrilled to partner with API to provide enhanced support to health innovators, including entrepreneurs, startups, SMEs, and researchers. This collaboration leverages the advanced simulation capabilities at CAMS to offer crucial usability and validation studies, significantly reducing development costs and accelerating time-to-market. By combining our resources and expertise, we aim to drive innovation and foster a vibrant life sciences ecosystem in Edmonton and beyond." - John Sutherland, director, Centre for Advanced Medical Simulation, NAIT
"CAMS has been instrumental in enabling us to develop and iterate on our technology at a rate we could not have achieved otherwise. The simulation tools, expertise, and access to users at CAMS enabled us to understand our market and develop our technology at a substantially faster rate." - Dr. Preetam Anbukarasu, Synapsis Medical Technologies CEO
"This partnership will be a catalyst for growth for many upcoming life science innovators by providing access to simulation testing during their research and development phases. This collaboration between API and NAIT reduces barriers, allowing more entrepreneurs to conduct the necessary testing to fast track development with sights set on regulatory approval." - Dr. Truong Ta, VP of Commercialization & Partnerships at API
For more information
11762-106 Street N.W.
Edmonton Alberta
Canada T5G 2R1
www.nait.ca
